Login / Signup
Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the 'VEDERA' trial.
Rudresh Shukla
Paul Emery
Maya H Buch
Published in:
Rheumatology (Oxford, England) (2021)
Keyphrases
</>
disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
phase iii
study protocol
juvenile idiopathic arthritis
clinical trial
phase ii
high intensity
interstitial lung disease
randomized controlled trial
open label